KLF6-SV1 is a new prognostic biomarker in postoperative patients with non-small cell lung cancer
Nan Zhang,1 Zhe Li,2 Wei Xiao,3 Fei Yang,4 Wei Gao,4 Zhi-Gang Sun3 1Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan, People’s Republic of China; 2Department of Medical Examination, Jinan Central Hospital Affiliated to Shandong University, Shandong Un...
Main Authors: | Zhang N, Li Z, Xiao W, Yang F, Gao W, Sun ZG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/klf6-sv1-is-a-new-prognostic-biomarker-in-postoperative-patients-with--peer-reviewed-article-CMAR |
Similar Items
-
The Klf6-related super enhancer regulates Klf6-SV2 expression mediated proliferation in human hepatoma (HepG2) cells
by: Kum Chol Ri, et al.
Published: (2019-10-01) -
Krüppel-Like Factor 6 Splice Variant 1: An Oncogenic Transcription Factor Involved in the Progression of Multiple Malignant Tumors
by: Kang Hu, et al.
Published: (2021-03-01) -
The Expression and Significance of Annexin Ⅱ in Lung Squamous Cell Cancer and Adenocarcinom
by: Zhongyan GUAN, et al.
Published: (2009-05-01) -
The Role of Wnt/β-Catenin Pathway Mediators in Aortic Valve Stenosis
by: Kashif Khan, et al.
Published: (2020-09-01) -
Expression of Interleukin–6 and Interleukin-6 Receptor in Ovine Oocytes During In vitroMaturation
by: Xi-an ZHAO, et al.
Published: (2012-08-01)